IP Library Granted Patent US 9,969,988
Granted Patent B2
US 9,969,988 · App. 15/115,028 · Granted May 15, 2018

Pipecolinic acid 4-hydroxylase and method for producing 4-hydroxy amino acid using same

Inventors: Makoto Hibi (Kyoto, JP); Jun Ogawa (Kyoto, JP); Ryoma Miyake (Kanagawa, JP); Hiroshi Kawabata (Kanagawa, JP)
Assignee: API CORPORATION
C12N9/0071C12P13/04C12P17/10C12P17/12C12Y114/00C12Y114/11006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,969,988
App. No.
15/115,028
Granted
May 15, 2018
Kind
B2
Abstract

The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells containing the protein, a treated product of the cells, and/or a culture liquid obtained by culturing the cells, with α-amino acid to produce 4-hydroxy amino acid: (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide having an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity.

Claims (15)

1. A method for producing a 4-hydroxy amino acid, said method comprising reacting:

a pipecolic acid 4-hydroxylase protein, a cell(s) comprising said protein, a treated product of said cell(s), and/or a culture liquid obtained by culturing said cell(s),

with α-amino acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce the 4-hydroxy amino acid;

wherein the pipecolic acid 4-hydroxylase protein is selected from the group consisting of:

(A) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, or 18; and

(B) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, or 18 except that 1 to 20 amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity.

2. The method for producing a 4-hydroxy amino acid according to claim 1 , wherein said α-amino acid has the following General Formula (I):

wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure, and

said 4-hydroxy amino acid has the following General Formula (II):

wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure.

3. The method for producing a 4-hydroxy amino acid according to claim 1 , wherein said α-amino acid is pipecolic acid, and said 4-hydroxy amino acid is 4-hydroxy-L-pipecolic acid.

4. The method for producing a 4-hydroxy amino acid according to claim 1 , wherein said cell comprising pipecolic acid 4-hydroxylase is a cell transformed with a DNA encoding pipecolic acid 4-hydroxylase protein.

5. The method for producing a 4-hydroxy amino acid according to claim 4 , wherein said DNA encoding pipecolic acid 4-hydroxylase protein is selected from the group consisting of:

(D) a DNA comprising the nucleotide sequence of SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17; and

(E) a DNA comprising the nucleotide sequence of SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 except that 1 to 60 nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2016
From: HIBI, MAKOTO; OGAWA, JUN; MIYAKE, RYOMA; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 039282/0849 →
Priority Claims (1)
JP 2014-017716 · Jan 31, 2014 · national
Continuity (1)
Related Publication 20160348081A1 · Dec 1, 2016